Insulin Detemir and Fluoxetine Interaction

Understanding the Insulin Detemir and Fluoxetine Interaction

FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Insulin Detemir belongs to the Long-Acting Insulin class and Fluoxetine belongs to the Selective Serotonin Reuptake Inhibitor (SSRI) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Fluoxetine can interfere with how your body manages sugar, which increases the risk of your blood sugar falling too low while on insulin. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Insulin Detemir has 11 total documented interactions on file in this dataset, and Fluoxetine has 68. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Monitor your blood sugar levels closely and ask your doctor if your insulin dose needs to be changed. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Insulin Detemir or Fluoxetine based on a web page, speak with your prescriber or pharmacist before making any change.